<DOC>
	<DOC>NCT01568944</DOC>
	<brief_summary>The investigators hypothesize that blood dendritic cells harbor pathogens from the oral cavity in chronic periodontitis and disseminate these pathogens to atherosclerotic plaques.</brief_summary>
	<brief_title>Role of Infected Blood Dendritic Cells in Heart Disease Risk</brief_title>
	<detailed_description>To address this hypothesis, a clinical study in humans with moderate to severe chronic periodontitis has been designed. This is an interventional study involving scaling and root planing and two arms: 1. treatment with PO amoxocillin/metronidazole plus chlorhexidine oral rinse; 2. no antibiotics or oral rinse. It is expected that the antibiotics plus chlorhexidine will prevent the dendritic cell response to infection (bacteremia) elicited by scaling and root planing.</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>generalized moderate to severe chronic periodontitis diabetes antibiotics treatment within 3 months treatment with steroids, phenytoin, cyclosporin, coumadin presence of conditions requiring prophylactic antibiotics per AHA cancer, HIV, hepB, lupus, prediagnosed heart disease, renal disease smoker</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>periodontal</keyword>
	<keyword>disease</keyword>
	<keyword>dendritic</keyword>
	<keyword>cells</keyword>
	<keyword>antibiotics</keyword>
</DOC>